Modern rectal cancer treatment: the role of MR imaging, hospital variation and quality of life

dr. Tijmen Koëter
Promotor prof. dr. J.H.W. de Wilt, prof. dr. ir. T.W.J. Scheenen
Copromotor dr. D.K. Wasowicz - Kemps (Elisabeth-TweeSteden Ziekenhuis), dr. D.D.E. Zimmerman (Elisabeth-TweeSteden Ziekenhuis)
Institute Radboud Universiteit Nijmegen
Date 2024-05-17

This dissertation investigates the treatment of rectal cancer, focusing on differences between hospitals, the use of MRI, and the impact of treatments on quality of life.

Substantial variation exists between hospitals in both preoperative treatment and surgical decisions, although these differences generally have limited impact on overall survival. MRI plays an increasingly important role in staging the disease and evaluating treatment response. New techniques enable faster and more accurate imaging, although certain tumor types respond less well to treatment and are more difficult to assess.

Finally, the study shows that different surgical approaches affect quality of life. Patients with a permanent stoma often report lower quality of life, although these differences tend to decrease over time.

Overall, the findings contribute to further optimization and standardization of treatment and follow-up care for patients with rectal cancer.

Research

Overige afdelingen Imaging